The protective effects of Ribes diacanthum Pall on cisplatin-induced nephrotoxicity in mice
Dados Bibliográficos
| ID | 14740620 |
|---|---|
| Autores | Akhtolkhyn Tilyek (China Pharmaceutical University), Chengzhi Chai (0000-0002-6122-0643, China Pharmaceutical University), Xiaoli Hou (0000-0001-5299-6725, China Pharmaceutical University), Baoping Zhou (0009-0002-8960-5163, China Pharmaceutical University), Chunlei Zhang (0000-0001-9765-258X, China Pharmaceutical University), Zhengyu Cao (0000-0002-2692-2949, China Pharmaceutical University, autor correspondente), Boyang Yu (0000-0002-1401-9250, China Pharmaceutical University, autor correspondente) |
| Ano | 2016 |
| Volume | 178 |
| Páginas | 297-306 |
| Data de publicação | 2016-02-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | Journal of Ethnopharmacology (JOURNAL) |
| Identificadores do periódico | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2015.10.003 |
| PMID | 26481606 |
| OpenAlex | W1953259002 |
| Idioma | EN |
| Citações recebidas | 4 |
| Referências citadas | 22 |
Antioxidant · Apoptosis · Chemotherapy · Cisplatin · Creatinine · Intraperitoneal injection · Kidney · Lipid peroxidation · Nephrotoxicity · Reactive oxygen species · Superoxide dismutase · Acute Lymphoblastic Leukemia research · Chemistry · Chemotherapy-induced organ toxicity mitigation · Medicine · Methemoglobinemia and Tumor Lysis Syndrome · Biochemistry · Endocrinology · Internal Medicine · Pharmacology
Renoprotective activity of Ribes diacanthum pall (RDP) against inflammation in cisplatin-stimulated mice model and human renal tubular epithelial cells
Ribes diacanthum Pall (RDP) ameliorates UUO-induced renal fibrosis via both canonical and non-canonical TGF-β signaling pathways in mice
Multi-dimensional analytical strategy for Ribes diacanthum Pall. to identify renoprotective small molecules
Ribes diacanthum Pall modulates bile acid homeostasis and oxidative stress in cholestatic mice by activating the Sirt1/FXR and Keap1/Nrf2 signaling pathways
| Obras citantes distintas | 4 |
|---|---|
| Citações por ano | 0,57 |
| Intervalo de citações | 2019 - 2025 (7) |
| Velocidade de citação | recent |
| Altamente citado | Não |
| Tipos de citação | Neutras: 4 |